林莺莺 副主任技师
信息来源:医学技术与工程学院  发布时间:2026-03-29   动态浏览次数:13

一、招生简介

姓名

林莺莺

性别

女

职称

副主任技师

硕士招生专业(领域)

医学技术(医学检验技术)(专业学位)

所在单位/(学系/科室)及

联系邮箱

福建省肿瘤医院检验科

linyingying226121@fjmu.edu.cn

二、个人简介

1.基本情况

林莺莺,性别女,1980年10月生,硕士,副主任技师,硕士研究生导师,2018年1月于j9九游会免疫专业获硕士学位,主要研究方向:肿瘤基础与临床研究,现任福建省肿瘤医院检验科科秘书和教学秘书。

2.人才称号及主要学术兼职

现兼任中国抗癌协会肿瘤标志专业委员会青年委员,

中国抗癌协会肿瘤标志专业委员会肿瘤测序及大数据分析专委会委员,

中国医疗器械行业协会医用质谱创新发展分会委员,

福建省抗癌协会肿瘤标志专业委员会委员和秘书,

福建省免疫学会免疫与分子诊断专业委员会委员,

福建省医学会检验医学分会检验医学科普学组成员,

福建省医师协会医学检验科医师分会检验教学及继续教育学组组员,

福建省肿瘤医院药物临床试验伦理委员会委员。

3.主持科研项目、发表学术论文及获得科研奖励

先后主持福建省自然科学基金面上项目2项、福建省科技创新联合资金项目1项、福建省卫健委创新课题基金项目1项和福建省卫健委中青年骨干课题基金项目1项等。

近五年以第一作者和通讯作者在Adv.Sci.、Journal of Translational Medicine、BMC Cancer等SCI刊物上发表研究论文12篇(被引用次数超过10次)

(1)Lin Y(林莺莺)#,Xiao Y#, Luo L#, Lin L#,Lin Z, Sun C, Cui Z*. LDHC4 promotes ovarian cancer progression through H4K12 lactylation to regulate PGK1 expression and modulate glycolysis.Journal of Translational Medicine.2026, DOI: 10.1186/s12967-026-07695-0.

(2)Lin Y(林莺莺)#, Ma Y#, Chen Y, Huang Y, Lin J, Xiao Z*, Cui Z*. Diagnostic and prognostic performance of serum GPC3 and PIVKA-II in AFP-negative hepatocellular carcinomaand establishment of nomogram prediction models. BMC Cancer. 2025 Apr 17;25(1):721.

(3)ZhaoleiCui#,ChaoqiangZheng#,YingyingLin(林莺莺)#,et al. Lactate Dehydrogenase C4 Accelerates Triple-Negative Breast Cancer Progression by Promoting Acetyl-CoA Acyltransferase 2 Lactylation to Increase Free Fatty Acid Accumulation. Adv.Sci.2025,e11849.

(4)Yingying Lin(林莺莺)#, Yun Li, Zhaolei Cui* and Zhenzhou Xiao*.Upregulated Lactate Dehydrogenase C4 Promotes Hepatocellular Carcinoma Progression Via Accelerating Glycolysis and Triggering the AKT/mTOR Signaling Pathway. Biomed J Sci & Tech Res.2025.61.009541.

(5)Cheng Sun#, Dan Hu#, Wei Peng#, Zhaolei Cui*, Yingying Lin(林莺莺)*. Emerging role of histone and non-histone lactylation in metabolic reprogramming of female-specific malignancies. World Journal of Surgical Oncology. 2026, 24:29

(6)YingyingLin(林莺莺),YunLi,ZhaoleiCui*,ZhenzhouXiao*.Upregulated Lactate Dehydrogenase C4 Promotes Hepatocellular Carcinoma Progression Via Accelerating Glycolysisand Triggering the AKT/mTOR Signaling Pathway.BiomedJSci&TechRes,2025,61(1):53226-53233.

(7)Cui Z, Zheng C, You Y, He S, Jiang S, Chen Y, Lin Y*(林莺莺), Xiao Z*. Comprehensive Analysis of the Prognostic Implications and Biological Function of HDACs in Liver Hepatocellular Carcinoma. Int J Med Sci. 2024 Oct 28;21(14):2807-2823.

(8)CuiZ#,LiY#,LinY(林莺莺),ZhengC,LuoL,HuD,ChenY,XiaoZ,SunY.Lactylp roteome analysis indicates histoneH4K12 lactylation as a novelbiomarker in triple-negative breast cancer. Front Endocrinol (Lausanne). 2024 May 8;15:1328679.

(9)ZhaoleiCui,JingWu,YingyingLin*(林莺莺),ZhenzhouXiao*.Construction of acirc RNA-miRNA-mRNA Network and Prognostic Model to Unveil Prognosis and Immunotherapy Prospects of Hepatocellular Carcinoma. Biomed J Sci & Tech Res. 2024; 54(3): 45899-45908.

(10)WuJ,ChenY,LinY*(林莺莺),LanF*,CuiZ*.Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer.FrontOncol.2022Nov2;12:936767

(11)Lin Y(林莺莺), Zhou X, Peng W, Wu J, Wu X*, Chen Y*, Cui Z*. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer. BMC Cancer. 2021 Sep 26;21(1):1062.

(12)CuiZ#, LinY#(林莺莺),HuD#,WuJ,PengW,ChenY.Diagnostic and Prognostic Potential of Circulating and Tissue BATF2 in Nasopharyngeal Carcinoma.Front MolBiosci.2021 Oct 28;8:724373.

(13)Cui Z#, Lin Y#(林莺莺), Luo X, Chen Y. Cancer-Testis Antigen Lactate Dehydrogenase C4 in Human Cancers:Old and New Perspectives.BiomedJSci&TechRes.2021;34(1):26453-26455

获奖情况:

2024年度福建省抗癌协会科技进步奖三等奖:崔兆磊,陈燕,林莺莺,胡丹,吴秀凤. 乳酸脱氢酶C4在乳腺癌中的研究与应用,证书编号:2024-FKJ-3-05-01。

 
Baidu
map